Microsoft Stock Forecast (NASDAQ: MSFT): Alibaba And Tencent Can Slow Down Microsoft Azure

motek 1The article was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology  – Senior Analyst at I Know First

Microsoft Stock Forecast

Summary:

  • I Know First has pessimistic market trend forecasts for Microsoft’s stock. Investors should do profit-taking while this stock still trades above $90.
  • Microsoft’s recent management team shake-up is not inspiring investors to rally behind the stock.
  • I can explain this algorithmic bearishness to Microsoft’s inability to dislodge Amazon Web Services’ leadership in cloud computing infrastructure services.
  • Based on most-recent quarter signals, hedge fund managers have a very negative sentiment over Microsoft. No real revenue/profit numbers for Azure is discouraging.
  • Azure is unlikely to gain a foothold in China’s $103 billion cloud computing industry. Alibaba Cloud will dominate China and threaten current global leaders.

Verizon stock forecastRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Successful Stock Forecast: Capston Turbine Corporation (NASDAQ: CPST) Gained High Momentum Of 26.39% In 3 Days

Successful Stock Forecast

“A key component to Capstone’s growth strategy is to increase our quarterly aftermarket service revenue and expand aftermarket gross margins to the point that they cover 100% of our quarterly operating costs”

– Darren Jamison, President and Chief Executive Officer of Capstone

CPST office

[Image Source: Regatta Solutions]

Over the 3 days period starting from April 9, 2018, Capstone Turbine’s stock price experienced steep price rise of more than 26%. Taking into account the overall CPST stock performance of +49.35% during fiscal year ended on March 31, 2018, it is it is reasonable to

Read More

Amazon Stock Forecast (NASDAQ: AMZN): Why You Should Now Go Long On Amazon

motek 1The article was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology  – Senior Analyst at I Know First

AMZN Stock Forecast

Summary:

  • In spite of Trump’s attack against Amazon, I am endorsing the company as a good long-term investment.
  • Amazon Web Services is the undisputed leader in cloud computing infrastructure services. It has a good chance to win the $10 billion contract from the U.S. Defense Department.
  • The 100 million-strong Amazon Prime subscribers’ army also makes Amazon’s leadership in e-commerce invidious and indomitable.
  • Amazon doesn’t need Flipkart. It already has a strong presence in India. The new international shopping feature of the Amazon mobile app is also a global tailwind for Amazon.
  • AMZN has bullish 90-day and one-year algorithmic market trend forecast from I Know First.

Amazon stock forecastRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Quick Win by the Algorithm: Sangamo Therapeutics (NASDAQ: SGMO) Returns Up To 278.00% In 1 Year And Promises Bright Future

” This year we continue the important work of laying the foundation for Sangamo as a sustainable, fully integrated company that develops, manufacturers and commercializes novel genomic therapies on our own and, where appropriate, in collaboration with industry partners. “

-Sandy Macrae, CEO of Sangamo.

[Image source: Businesswire.com]

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a clinical stage biopharmaceutical company that focuses on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene

Read More

Quick Win by the Algorithm: Geron Corporation (NASDAQ: GERN) Treats Investors With Stock Up 24.71% In 3 Days

Quick Algorithm

“With the preliminary data from IMerge presented at ASH, we now have clinical data in three blood cancers, ET, MF and MDS, where imetelstat exhibits potential disease modifying activity by inhibiting the progenitor cells of the malignant clones that drive the underlying diseases”

– said John A. Scarlett, M.D., Geron’s President and Chief Executive Officer.

(Image Source: www.troutaccess.com)

Geron Corporation (NASDAQ: GERN) operates as a biopharmaceutical company. The company supports the clinical stage development of imetelstat, a telomerase inhibitor for the

Read More

Quick Win by the Algorithm: Nektar Therapeutics (NASDAQ: NKTR) Treats Investors With Stock Up 383.54% In 1 Year

Quick Algorithm

“This past year was truly transformational for Nektar as we achieved a number of successes with Nektar medicines across our three key therapeutic areas of immuno-oncology, immunology and pain”

– Howard W. Robin, President and Chief Executive Officer of Nektar Therapeutics

(Image Source: Nektar)

Over the past year Nektar Therapeutic’s stock price steadily grew from $21.60 to $104.51 per share, outperforming the market by more than 365%. So what is the driver behind that growth  and what happened during 2017 financial year? The reason lies in the company’s results

Read More

AMAT Stock Forecast for 2018: Applied Materials Inc. Shows Double Digit Growth In 2 Months And Keeps On Rising

Gleb ZInkovskii_photo

The article was written by Gleb Zinkovskii, a Financial Analyst at I Know First.

“Our broad portfolio of capabilities and products puts us in a great position to outperform our markets and we’re confident that each of our three major business segments can deliver strong double-digit growth in 2018.”

– Gary Dickerson, president and CEO of Applied Materials

AMAT Stock Forecast for 2018

[Image Source: via Wikimedia Commons]

Founded in 1967, Applied Materials, Inc. is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the

Read More